Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators..

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360.

2.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators..

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

3.

[Race and the use of dental health services by the elderly].

Souza EH, Oliveira PA, Paegle AC, Goes PS.

Cien Saude Colet. 2012 Aug;17(8):2063-70. Portuguese.

4.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators..

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240.

PMID:
21975206
5.

[On the problem of cryoglobulinemia].

IAVORKOVSKII LI, SANDLER GP, SOLOVEI DIa, PAEGLE AG.

Ter Arkh. 1961 Jan;33:96-101. Russian. No abstract available.

PMID:
13717322

Supplemental Content

Loading ...
Support Center